Browse Category

Stock Market News News 16 December 2025

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Falling, What Analysts Forecast, and How the Microsoft AI Deal Shapes 2026 (Dec. 16, 2025)

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Falling, What Analysts Forecast, and How the Microsoft AI Deal Shapes 2026 (Dec. 16, 2025)

IREN Limited stock is back in the spotlight on December 16, 2025, as the high-flying “AI infrastructure” trade collides with a sharp momentum pullback — even while the company continues to point to a massive long-term runway from its GPU
D-Wave Quantum (QBTS) Stock News on Dec. 16, 2025: Jefferies Starts Coverage With a Buy, Wall Street Targets Stack Up, and the Bull–Bear Tug-of-War Intensifies

D-Wave Quantum (QBTS) Stock News on Dec. 16, 2025: Jefferies Starts Coverage With a Buy, Wall Street Targets Stack Up, and the Bull–Bear Tug-of-War Intensifies

D-Wave Quantum Inc. (NYSE: QBTS) is back in the quantum-computing spotlight on December 16, 2025, after Jefferies initiated coverage with a Buy rating and a $45 price target—a fresh endorsement in a sector that’s been equal parts hype engine and
Fermi Inc (FRMI) Stock Swings Again on Dec. 16, 2025: Project Matador Funding Fallout, Latest News, Analyst Targets, and What Investors Are Watching

Fermi Inc (FRMI) Stock Swings Again on Dec. 16, 2025: Project Matador Funding Fallout, Latest News, Analyst Targets, and What Investors Are Watching

Fermi Inc. (NASDAQ: FRMI) stock is back in the spotlight on Tuesday, December 16, 2025, as the newly public AI-energy and data-center infrastructure developer continues to absorb the market shock from a key tenant-related funding reversal tied to its flagship
Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is back on traders’ radars on December 16, 2025, after a sharp, high-volume move that has pushed the clinical-stage biotech into “crowded trade” territory—where catalysts, liquidity, and sentiment can matter as much as fundamentals. As
Mastercard (MA) Stock After Hours Today (Dec. 15, 2025): Swipe-Fee Lawsuit Headlines, New Company Outlook, and the Key Data to Watch Before Tuesday’s Open

Mastercard (MA) Stock After Hours Today (Dec. 15, 2025): Swipe-Fee Lawsuit Headlines, New Company Outlook, and the Key Data to Watch Before Tuesday’s Open

Mastercard Incorporated (NYSE: MA) finished Monday’s session with a modest pullback, and the stock drifted slightly lower in after-hours trading—typical behavior for a mega-cap payments name heading into a macro-heavy week. In late trading after Monday’s close (Dec. 15, 2025),
AST SpaceMobile (ASTS) Stock After Hours Today (Dec. 15, 2025): BlueBird 6 Launch Delay, Insider-Selling Headlines, and What to Watch Before Tuesday’s Open

AST SpaceMobile (ASTS) Stock After Hours Today (Dec. 15, 2025): BlueBird 6 Launch Delay, Insider-Selling Headlines, and What to Watch Before Tuesday’s Open

AST SpaceMobile, Inc. (NASDAQ: ASTS) ended Monday, December 15, 2025, in sharp reverse—then continued sliding after the closing bell as investors recalibrated around one near-term catalyst that matters more than almost anything else for the company right now: execution on
1 23 24 25 26 27 46
Go toTop